A case of successful resection after FOLFIRINOX in a patient with borderline resectable pancreatic adenocarcinoma

被引:0
作者
Yusuke Shimodaira
Seiji Ohigashi
Koyu Suzuki
Gautam A. Deshpande
Keiichiro Ohta
机构
[1] St. Luke’s International Hospital,Department of Gastrointestinal Surgery
[2] St. Luke’s International Hospital,Department of Pathology
[3] St. Luke’s Life Science Institute,Center for Clinical Epidemiology
关键词
Neoadjuvant therapy; FOLFIRINOX; Borderline resectable pancreatic cancer; Pancreatic adenocarcinoma;
D O I
10.1007/s13691-015-0219-5
中图分类号
学科分类号
摘要
Pancreatic adenocarcinoma (PAC), one of the most aggressive human neoplasms, continues to have an exceedingly poor prognosis. With the advance of diagnostic techniques, a distinct subset of pancreatic cancer labeled “borderline resectable pancreatic cancer” has emerged. Optimal treatment of this disease with a multidisciplinary approach including neoadjuvant and adjuvant therapy remains controversial. We describe a case of borderline resectable PAC treated with FOLFIRINOX (5-fluorouracil, oxaliplatin, irinotecan, and leucovorin) followed by successful pancreaticoduodenectomy. CT scan demonstrated a pancreatic head tumor attached to the superior mesenteric artery, subsequent to which the patient received FOLFIRINOX. Follow-up images showed no lymph node involvement or metastatic disease, suggesting that radical surgery would be curative. The patient underwent pancreaticoduodenectomy with negative margins and was subsequently diagnosed as Stage III (T3N0M0). Though requiring precise case selection and toxicity management, recent literature suggests that FOLFIRINOX is an effective neoadjuvant regimen in the setting of borderline resectable PAC.
引用
收藏
页码:26 / 30
页数:4
相关论文
共 50 条
[21]   Prognostic Factors in Patients With Borderline Resectable Pancreatic Ductal Adenocarcinoma Undergoing Resection [J].
Ren, Weizheng ;
Xourafas, Dimitrios ;
Ashley, Stanley W. ;
Clancy, Thomas E. .
AMERICAN SURGEON, 2022, 88 (06) :1172-1180
[22]   Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer [J].
Groot, Vincent P. ;
Blair, Alex B. ;
Gemenetzis, Georgios ;
Ding, Ding ;
Burkhart, Richard A. ;
Yu, Jun ;
Rinkes, Inne H. M. Borel ;
Molenaar, I. Quintus ;
Cameron, John L. ;
Weiss, Matthew J. ;
Wolfgang, Christopher L. ;
He, Jin .
EJSO, 2019, 45 (09) :1674-1683
[23]   Diagnosis and Management of Borderline Resectable Pancreatic Adenocarcinoma [J].
Schwarz, Lilian ;
Katz, Matthew Harold G. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2015, 29 (04) :727-+
[24]   Patient outcome according to the 2017 international consensus on the definition of borderline resectable pancreatic ductal adenocarcinoma [J].
Medrano, J. ;
Garnier, J. ;
Ewald, J. ;
Marchese, U. ;
Gilabert, M. ;
Launay, S. ;
Poizat, F. ;
Giovannini, M. ;
Delpero, J. R. ;
Turrini, O. .
PANCREATOLOGY, 2020, 20 (02) :223-228
[25]   Survival benefit of neoadjuvant FOLFIRINOX for patients with borderline resectable pancreatic cancer [J].
Waugh, Evelyn ;
Glinka, Juan ;
Breadner, Daniel ;
Liu, Rachel ;
Tang, Ephraim ;
Allen, Laura ;
Welch, Stephen ;
Leslie, Ken ;
Skaro, Anton .
ANNALS OF HEPATO-BILIARY-PANCREATIC SURGERY, 2024, 28 (02) :229-237
[26]   Contemporary Review of Borderline Resectable Pancreatic Ductal Adenocarcinoma [J].
Bonds, Morgan ;
Rocha, Flavio G. .
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (08)
[27]   Prognostic Factors for Patients with Borderline Resectable or Locally Advanced Pancreatic Cancer Receiving Neoadjuvant FOLFIRINOX [J].
Choi, Young Hoon ;
Lee, Sang Hyub ;
You, Min Su ;
Shin, Bang Sup ;
Paik, Woo Hyun ;
Ryu, Ji Kon ;
Kim, Yong-Tae ;
Kwon, Wooil ;
Jang, Jin-Young ;
Kim, Sun-Whe .
GUT AND LIVER, 2021, 15 (02) :315-323
[28]   Efficacy and safety of neoadjuvant FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: improved efficacy compared with gemcitabine-based regimen [J].
Yoo, Changhoon ;
Kang, Jihoon ;
Kim, Kyu-Pyo ;
Lee, Jae-Lyun ;
Ryoo, Baek-Yeol ;
Chang, Heung-Moon ;
Lee, Sang Soo ;
Park, Do Hyun ;
Song, Tae Jun ;
Seo, Dong Wan ;
Lee, Sung Koo ;
Kim, Myung-Hwan ;
Park, Jin-Hong ;
Hwang, Dae Wook ;
Song, Ki Byung ;
Lee, Jae Hoon ;
Kim, Song Cheol .
ONCOTARGET, 2017, 8 (28) :46337-46347
[29]   Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma [J].
Alvarez, R. ;
Ales, I. ;
Diaz, R. ;
de Paredes, B. G. ;
Hidalgo, M. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10) :1193-1198
[30]   Initial Experience in the Treatment of "Borderline Resectable'' Pancreatic Adenocarcinoma [J].
Busquets, Juli ;
Fabregat, Juan ;
Verdaguer, Helena ;
Laquente, Berta ;
Pelaez, Nuria ;
Secanella, Luis ;
Leiva, David ;
Serrano, Teresa ;
Cambray, Maria ;
Lopez-Urdiales, Rafael ;
Ramos, Emilio .
CIRUGIA ESPANOLA, 2017, 95 (08) :447-456